ANTICOV Trial
The Finance Manager - Grants Management at DNDi oversees financial activities related to grant and budget management, ensuring donor compliance, accurate reporting, and effective financial oversight throughout the grant lifecycle. The role collaborates with project, external relations, and finance teams, supports proposal development, and leads financial coordination of donor audits and budgeting tools.
The ANTICOV clinical trial aimed to identify treatments to treat mild and moderate cases of COVID-19 early and prevent hospitalizations in low-resource settings across Africa, Asia, and Latin America. Launched in September 2020 by a 27-organization consortium coordinated by the Drugs for Neglected Diseases initiative (DNDi), it was one of the largest multi-country trials focusing exclusively on mild and moderate COVID-19 cases. The study was completed in December 2022, and its collaborative momentum led to the creation of the PANTHER platform to strengthen pandemic preparedness in Africa.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ANTICOV Trial.
ANTICOV Trial didn’t post a salary, so this is our estimate from similar listings.